Form 8-K - Current report:
SEC Accession No. 0001193125-24-060033
Filing Date
2024-03-06
Accepted
2024-03-06 08:15:54
Documents
14
Period of Report
2024-03-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K d815831d8k.htm   iXBRL 8-K 29858
  Complete submission text file 0001193125-24-060033.txt   149938

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrus-20240305.xsd EX-101.SCH 2840
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrus-20240305_lab.xml EX-101.LAB 17166
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrus-20240305_pre.xml EX-101.PRE 10781
15 EXTRACTED XBRL INSTANCE DOCUMENT d815831d8k_htm.xml XML 3560
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37773 | Film No.: 24724426
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)